Cargando…
Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first h...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340371/ https://www.ncbi.nlm.nih.gov/pubmed/25733943 http://dx.doi.org/10.2147/JBM.S52783 |
_version_ | 1782359018497376256 |
---|---|
author | Hequet, Olivier |
author_facet | Hequet, Olivier |
author_sort | Hequet, Olivier |
collection | PubMed |
description | Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first harvested in BM and later in CB and PB, as studies showed interesting features of such grafts. All harvesting methods were in use throughout the years, except BM harvesting for HSPC autologous transplantation, which was replaced by PB harvesting. BM, CB, and PB harvesting methods have been developed, and materials and devices technically improved to increase the number of HSPCs harvested. In parallel, knowing the features of the donors or patients associated with successful numbers of HSPCs allows the adaptation of appropriate harvesting methods. Moreover, it is important to ensure the safety of donors or patients while harvesting. This review describes the methods used for harvesting based on recent studies or developments around these methods, and more particularly, the means developed to increase the numbers of HSPCs harvested in each method. It also explains briefly the influence of technical improvements in HSPC harvesting on potential changes in HSPC graft composition. |
format | Online Article Text |
id | pubmed-4340371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43403712015-03-02 Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility Hequet, Olivier J Blood Med Review Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first harvested in BM and later in CB and PB, as studies showed interesting features of such grafts. All harvesting methods were in use throughout the years, except BM harvesting for HSPC autologous transplantation, which was replaced by PB harvesting. BM, CB, and PB harvesting methods have been developed, and materials and devices technically improved to increase the number of HSPCs harvested. In parallel, knowing the features of the donors or patients associated with successful numbers of HSPCs allows the adaptation of appropriate harvesting methods. Moreover, it is important to ensure the safety of donors or patients while harvesting. This review describes the methods used for harvesting based on recent studies or developments around these methods, and more particularly, the means developed to increase the numbers of HSPCs harvested in each method. It also explains briefly the influence of technical improvements in HSPC harvesting on potential changes in HSPC graft composition. Dove Medical Press 2015-02-18 /pmc/articles/PMC4340371/ /pubmed/25733943 http://dx.doi.org/10.2147/JBM.S52783 Text en © 2015 Hequet. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Hequet, Olivier Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title | Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title_full | Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title_fullStr | Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title_full_unstemmed | Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title_short | Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
title_sort | hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340371/ https://www.ncbi.nlm.nih.gov/pubmed/25733943 http://dx.doi.org/10.2147/JBM.S52783 |
work_keys_str_mv | AT hequetolivier hematopoieticstemandprogenitorcellharvestingtechnicaladvancesandclinicalutility |